Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Richard Goldberg, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01652196
First received: July 25, 2012
Last updated: October 14, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)